Navigation Links
Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook
Date:2/14/2008

espectively, resulting from the adoption of Statement of

Financial Accounting Standards No. 123 (Revised) "Share-Based Payment"

(SFAS 123(R)) as of January 2, 2006. Corresponding amounts for fiscal

2007 and 2006 were $6.8 million and $4.3 million, respectively. Such

amounts were reflected in corporate expenses.

6) Components of EBITDA included the following:

A) Restructuring and integration costs for the fourth quarter and

fiscal 2007 were $0.3 million and $2.4 million, respectively, and

for the fourth quarter and fiscal 2006 were $3.3 million and $7.7

million, respectively. These costs included the following items:

(i) $0.3 million and $2.4 million for the fourth quarters of 2007

and 2006, respectively, and $2.3 million and $6.1 million for

fiscal 2007 and 2006, respectively, resulting from restructuring

and integration activities relating to the Healthfield

acquisition; (ii) $0.1 million for fiscal 2007 and $0.9 million

for both the fourth quarter of 2006 and fiscal 2006 in connection

with a restructuring plan associated with the Company's hospice

operations; and (iii) $0.7 million for fiscal 2006 resulting from

a restructuring plan associated with the Company's CareCentrix

operations.

Restructuring and integration costs for the fourth quarters and

fiscal 2007 and 2006 were reflected as follows for segment

reporting purposes (dollars in millions):

4th Quarter Fiscal Year

2007 2006 2007 2006

Home Health $0.1 $0.6 $0.6 $2.3

CareCentrix - - - 0.7

Other Related Service
'/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011
2. Gentiva(R) Health Services Agrees to Acquire Major Home Health Provider in CON State of Mississippi
3. Gentiva(R) Health Services Promotes Boelsen to Senior Vice President, CareCentrix(R)
4. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
5. Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York
6. Gentiva(R) Health Services Schedules Third Quarter Earnings Call and Web Cast for Thursday, November 1, 2007
7. Gentiva(R) Health Services Files Universal Shelf Registration Statement
8. XTend Medical (XMDC) Begins Remote Diabetic Telehealth Program
9. Underserved Women and Children in Oakland County Get Big Boost for Free Health Care from Chrysler 300C Lease Giveaway
10. AIDS Action Asks Mass. Public Health Council to Forge a State AIDS Plan to Help Stop HIV/AIDS Here
11. Is a Common Cold a Serious Health Condition?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...- The Providence Service,Corporation (Nasdaq: P...mpany,s,Chief Operating Officer, has been appoint...is, appointment fills the vacancy left by the Apri...rns the board to six members. Mr.,Norris will no.... Norris, age 41, has been with Providence since i...
(Date:11/21/2008)...ennox-Gastaut syndrome , , FRIDAY, Nov. ...ufinamide) has been approved as a supplementary tr...x-Gastaut syndrome, the U.S. Food and Drug Adminis...sed on results of a four-month clinical trial that...nts who took a placebo, those who took the drug ha...
(Date:11/21/2008)...re/ -- New research at West Virginia University ... product aimed at young adults is catching on. And...l Snus - touted as a socially acceptable way to sa...s of nicotine. , , "Camel Snus contains mor...ruce Adkins of the state Division of Tobacco Preve...
(Date:11/21/2008)... -- U.S. News & World Report and the National ...Choice(R) HealthPlan of South Carolina in the top ...d in U.S. News & World Report,s issue this wee...he nation,s best health plans based on clinical qu...scores. NCQA and U.S. News & World Report rank...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2
...u.s., mothers who breastfed their babies in public... act was made to prove that breastfeeding was an a...h mother and child. The U.S. Healthy People 2010 ...n of mothers who choose to breastfeed their babies...
... National Institutes of Health (NIH) and the Cente...oday that more than one-third of adults having dia...abetes in adults aged 20 and older has increased f...period between 1988 to 1994 and 1999 to 2002. How...
...ervations on one side and on the other side increa... does not suffer is the UPA Government’s please-a...eft supporters announced that 27 per cent of the s...ns would be available to Other Backward Classes (O...
...une diseases, named Juvenile rheumatoid arthritis ...which inversely affect health-related quality of l...gests patient prognosis in adults – study finds. B...d. Arthritis Care & Research journal published a...
Other Medicine News:Health News:Breastfeeding Mothers Arrested For Public Indecency 2Health News:Undetected Cases Of Diabetes Boom In The US 2Health News:Undetected Cases Of Diabetes Boom In The US 3Health News:Undetected Cases Of Diabetes Boom In The US 4Health News:The Government’s Balancing Act on Reservatio 2Health News:The Government’s Balancing Act on Reservatio 3Health News:Socioeconomic Status Plays A Role In Juvenile Rheumatoid Arthritis 2
(Date:11/20/2008)...wire/ -- Epeius Biotechnologies,announced today t... in,chemotherapy-resistant metastatic soft tissue...nt P. Chawla, principal investigator, at the CTOS ...r 13-15, 2008. Patients received,repeated infusio...nalysis of,safety and efficacy data showed no maj...
(Date:11/20/2008)...20 Arpida (SWX:,ARPN) a...ory Committee of the,U.S. Food and Drug Administr...l of intravenous iclaprim, an antibiotic currently...h complicated skin and skin structure infections,...sistant Staphylococcus,aureus (MRSA). , Ar...
(Date:11/20/2008)...linical data from a prospective,registry presente...ws DVT,treatment with the Trellis(R) Peripheral I... Clara, CA) successfully breaks up the blood clot ...is technique, called isolated pharmacomechanical t... safely than current catheter-directed thrombolysi...
(Date:11/19/2008)...tatistical significance , , ISELIN, N.J., N...ion (Nasdaq: PARS ) today announced results from...ulsion (NE) drug delivery technology formulated wi...lti-center, randomized, double-blinded, placebo-co...f the Company,s 3% Diclofenac Diethanolamine NanoE...
Breaking Medicine Technology:Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Off Hours Heart Patients Less Likely to Get Angioplasty 17343 1Off Hours Heart Patients Less Likely to Get Angioplasty 17343 2Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 1Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 2Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 3Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 4Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results 4742 1Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results 4742 2Crop management strategies key to a healthy Gulf planet 2980 1Crop management strategies key to a healthy Gulf planet 2980 2Crop management strategies key to a healthy Gulf planet 2980 3
...ong ADHD Patients Nearly Triple That,of General Po..., INDIANAPOLIS, May 23, 2007 /PRNewswire-FirstCall...ttera(R) (atomoxetine HCl),improved symptoms of At...patients with comorbid alcohol abuse disorder, sug... with Strattera in,patients with both disorders. R...
...ty Demonstrated Among Patients with,Active Disease... --,ChemoCentryx, Inc., a clinical-stage biopharma...g and commercializing,orally-administered therapeu...ata today from the company,s Phase 2 clinical tria...-inflammatory agent,that targets the chemokine rec...
Other Medicine Technology:Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 2Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 3Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 5Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 6ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 2ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 3ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 4ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 5
Ideal for chest procedures.
Male Compression Vests
Female Compression VEST w/sleeves
Male Support Brief
Medicine Products: